North Midlands MND Care and Research Network Centre

Royal Stoke University Hospital

The North Midlands MND Care and Research Network is based at University Hospitals North Midlands NHS Trust which has sites at Royal Stoke University Hospital and County Hospital, Stafford. It cares for patients with ALS throughout Staffordshire and parts of Cheshire.

RoyalStokeLogo
Royal Stoke University Hospital

Royal Stoke University Hospital is a large teaching hospital and the main site of University Hospitals North Midlands NHS Trust which also includes County Hospital in Stafford. Based here is the North Midlands MND Care and Research Network Centre which runs two MND MDT clinics a month, one at each site. The hospital has a generic research department with more than 40 dedicated research staff including those involved in administration.

Contact
Location
Royal Stoke University Hospital, Newcastle Road, Stoke-on-Trent, UK

Thomas Lambert

Consultant Neurologist

Thomas Lambert has been a Consultant Neurologist at University Hospitals North Midlands […]

Thomas Lambert
Current trials
Recruiting
Phase iii

ATLAS trial

Industry trial
Biogen is conducting a clinical trial to evaluate the efficacy and safety and of an investigational drug for adults who do not have any clinical signs or symptoms of Amyotrophic Lateral Sclerosis (ALS) (that definitely indicate the onset of ALS) but do carry a certain superoxide dismutase 1 (SOD1) gene variant.
Read more
Recruiting
Phase iii

FUSION trial

Industry trial
In this study we investigate the safety and efficacy of the study drug ‘ION363’ for the treatment of ALS caused by mutations in the FUS gene. About 1% to 5% of ALS cases are caused by FUS mutations.
Read more
Active
Phase iii

PHOENIX trial

Industry trial
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035' for the treatment of ALS.
Read more
Active
Phase iii

ADORE trial

Industry trial
Ferrer is conducting a phase 3 trial to evaluate the safety and potential efficacy of an investigational drug for people with Amyotrophic Lateral Sclerosis (ALS).
Read more
Active
Phase iii

TUDCA-ALS

Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more